ACE2 and viral infectious disease: Collectively, when considering involvement of mucosal cells such as paneth cells and Nφs, the use of Defensin-5 has been suggested as a competitive inhibitor of SARS-CoV-2 binding to ACE2, hence preventing viral infection [99].